avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Trp53
|
ENSMUSG00000059552.7 | transformation related protein 53 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Trp53 | mm10_v2_chr11_+_69580359_69580382 | 0.82 | 9.3e-10 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 17.9 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
4.2 | 12.7 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
3.8 | 11.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
2.6 | 10.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.4 | 7.0 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.4 | 5.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.3 | 5.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.0 | 8.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 6.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.8 | 3.3 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.7 | 3.7 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.7 | 2.2 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.7 | 4.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.6 | 5.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 1.9 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.5 | 4.1 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.4 | 1.7 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 7.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 2.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.8 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.3 | 1.6 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.3 | 1.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 1.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.7 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
0.2 | 1.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 3.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 1.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 2.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 3.4 | GO:0099623 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.2 | 3.1 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.2 | 2.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 2.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 2.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 2.2 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 9.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 2.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.1 | 0.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 2.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.1 | 2.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 3.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 2.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 6.1 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.0 | 1.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 1.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.4 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 2.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 2.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.4 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 1.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 2.7 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 2.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 1.6 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 2.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.7 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
1.0 | 6.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.0 | 4.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.9 | 18.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 5.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 2.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.7 | 10.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 5.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 6.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 1.1 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.3 | 9.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 2.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 3.9 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 2.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 7.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 8.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 17.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 7.6 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 4.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 1.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 1.6 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 11.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 3.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 4.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 1.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 3.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 2.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 1.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 3.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.7 | GO:0045178 | basal part of cell(GO:0045178) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.6 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
1.4 | 11.4 | GO:0050786 | Toll-like receptor 4 binding(GO:0035662) RAGE receptor binding(GO:0050786) |
1.0 | 8.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 3.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 2.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.6 | 3.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.6 | 17.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.6 | 2.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 1.7 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.6 | 2.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 6.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 2.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 4.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 2.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 2.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 2.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 12.7 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 7.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 2.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 1.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 6.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 3.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 8.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 2.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 2.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 8.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 2.6 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 1.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 7.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 2.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 1.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 3.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.4 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 2.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 3.5 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 1.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.7 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 2.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 10.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 15.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 4.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.9 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 3.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 3.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 2.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 2.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 17.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 5.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 6.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 8.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 3.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 2.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 9.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 6.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |